MBP and myeloid sarcoma: Significantly higher levels of anti-MBP antibodies were found in oligodendrocyte-derived EVs from patients with MS (13.23 ± 5.93 ng/mL) than from healthy controls (1.52 ± 2.44 ng/mL) (p=0.001) (Figures 4F, G).